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Abstract 
Metabolism of arachidonic acid by cyclooxygenase is one of the primary sources of reactive oxygen 
species in the ischemic brain. Neuronal overexpression of cyclooxygenase-2 has recently been shown to 
contribute to neurodegeneration following ischemic injury. In the present study, we examined the possibility 
that the neuroprotective effects of the cyclooxygenase-2 inhibitor nimesulide would depend upon reduction 
of oxidative stress following cerebral ischemia. Gerbils were subjected to 5 min of transient global cerebral 
ischemia followed by 48 h of reperfusion and markers of oxidative stress were measured in hippocampus 
of gerbils receiving vehicle or nimesulide treatment at three different clinically relevant doses (3, 6 or 12 
mg/kg). Compared to vehicle, nimesulide significantly (P<0.05) reduced hippocampal glutathione depletion 
and lipid peroxidation, as assessed by the levels of malondialdehyde (MDA), 4-hydroxy-alkenals (4-HDA) 
and lipid hydroperoxides levels, even when the treatment was delayed until 6 h after ischemia. Biochemical 
evidences of nimesulide neuroprotection were supported by histofluorescence findings using the novel 
marker of neuronal degeneration Fluoro-Jade B. Few Fluoro-Jade B positive cells were seen in CA1 region 
of hippocampus in ischemic animals treated with nimesulide compared to vehicle. These results suggest 
that nimesulide may protect neurons by attenuating oxidative stress and reperfusion injury following the 
ischemic insult with a wide therapeutic window of protection. 
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1. Introduction 
Neuronal loss following ischemic brain injury is a delayed process in which the primary injury is followed by 
a prolonged period of secondary neurodegeneration resulting in neurological dysfunction. It has been 
shown that pyramidal neurons in the hippocampal CA1 region are particularly sensitive to injury due to 
transient global ischemia, and neuronal cell death occurs within days after ischemia/reperfusion (Kirino, 
1982; Schmidt-Kastner and Freund, 1991). This phenomenon is referred to as delayed neuronal death 
(DND). Although not fully understood, ischemia-induced DND is probably associated with a myriad of 
biochemical events initially triggered by the extracellular accumulation of glutamate. In turn, this leads to 
membrane depolarization, increased concentrations of intracellular calcium, overproduction of reactive 
oxygen species and oxidative damage (Kitagawa et al., 1990; Nakamura et al., 1999; Urabe et al., 2000; 
Chan, 2001).  
 
Many factors, including high content of polyunsaturated fatty acids, high rate of oxidative metabolic activity, 
intense production of reactive oxygen metabolites, relatively low antioxidant capacity and low repair 
mechanism activity, suggest that neurons in the central nervous system are particularly prone to oxidative 
stress (Halliwell and Gutteridge, 1985; Liu, 2003). A large body of experimental evidences has 
demonstrated the involvement of reactive oxygen species in cerebral ischemia/reperfusion and cell death 
mechanisms (Kitagawa et al., 1990; Facchinetti et al., 1998; Chan, 2001). 
 
Previous studies have shown that one of the primary sources of reactive oxygen species in the ischemic 
brain is through the metabolism of arachidonic acid by cyclooxygenase (Nelson et al., 1992; Busija et al., 
1998; Chan, 2001). Two isoforms of cyclooxygenase have been described: cyclooxygenase-1 and 
cyclooxygenase-2. Cyclooxygenase-1 is expressed constitutively in many organs and contributes to the 
synthesis of prostanoids involved in normal cellular functions (Seibert et al., 1997). Cyclooxygenase-2 is 
thought to be an inducible enzyme, the expression of which is up-regulated in inflammation (Seibert et al., 
1997). Recently, cyclooxygenase-2 mRNA and protein levels have been shown to be significantly 
increased within neurons and vascular cells after cerebral ischemia and other insults that result in 
neurodegeneration (Nogawa et al., 1997; Nakayama et al., 1998; Koistinaho et al., 1999; Iadecola et al., 
1999). Cyclooxygenase-2 has become the focus of attention because it is the rate-limiting enzyme involved 
in arachidonic acid metabolism, thereby generating prostaglandins and thromboxanes, molecules that play 
important roles in supporting and sustaining the inflammatory response seen after cerebral ischemia (Vane 
et al., 1998; Iadecola and Alexander, 2001).  
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It is now well known that the administration of cyclooxygenase-2 selective inhibitors is able to confer 
protection against brain injury in relevant models of cerebral ischemia even when the treatment is delayed 
until several hours after ischemia (Nogawa et al., 1997; Candelario-Jalil et al., 2002a,b), suggesting that 
cyclooxygenase-2 activity is involved in the biochemical events that lead to delayed neuronal cell death. 
 
Nimesulide (N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide) is a non-steroidal anti-inflammatory drug 
with potent effects, showing a high affinity and selectivity for cyclooxygenase-2 (Cullen et al., 1998). 
Nimesulide readily crosses the intact blood-brain barrier in both humans and rodents (Taniguchi et al., 
1997; Cullen et al., 1998). Several recent studies have demonstrated a marked neuroprotective effect of 
nimesulide on chronic cerebral hypoperfusion (Wakita et al., 1999), kainate-induced excitotoxicity 
(Candelario-Jalil et al., 2000), quisqualic acid-induced neurodegeneration (Scali et al., 2000), diffuse 
traumatic brain injury (Cernak et al., 2001, 2002), glutamate-mediated apoptotic damage (Mirjany et al., 
2002) and induction of the expression of the B subunit of endogenous complement component C1q (C1qB) 
in transgenic mice with neuronal overexpression of human cyclooxygenase-2 (Spielman et al., 2002). 
 
Recently, we have found a significant neuroprotective effect of nimesulide in both global (Candelario-Jalil et 
al., 2002b) and focal cerebral ischemia (Candelario-Jalil et al., 2002c). In addition, previous results from 
our lab indicated that nimesulide is able to reduce hippocampal oxidative damage following excitotoxic 
brain injury induced by the systemic application of kainate (Candelario-Jalil et al., 2000). However, the 
effects of nimesulide on measures of oxidative stress in a model of cerebral ischemia had not been 
previously investigated.  
 
In the light of all these evidences and given that the activation of the cyclooxygenase pathway by cerebral 
ischemia, especially during reperfusion, accelerates conversion of arachidonic acid to prostaglandins and 
thromboxanes, producing reactive oxygen species such as hydroxyl radicals and superoxide radicals 
(Katsuki and Okuda, 1995; Miettinen et al., 1997), the purpose of this study was to examine the effects of 
clinically-relevant doses of nimesulide on measures of oxidative injury seen in the hippocampus after 
transient forebrain ischemia in gerbils.  
 
2. Materials and Methods 
2.1. Transient forebrain ischemia 
Studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals as 
adopted and promulgated by National Institutes of Health (Bethesda, MD, USA). Our institutional animal 
care and use committee approved the experimental protocol (No. 02/112). Adult male Mongolian gerbils 
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(Meriones unguiculatus, 12-15 weeks, 60-70 g) were subjected to transient global cerebral ischemia under 
diethyl ether anesthesia by occluding both common carotid arteries for 5 min with microaneurysmal clips 
(Sugita, Japan) exactly as in our previous reports (Candelario-Jalil et al., 2001, 2002a,b; Martínez et al., 
2001), which consistently resulted in delayed neuronal death in the CA1 region of the hippocampus (Kirino, 
1982; Candelario-Jalil et al., 2002a,b). Blood flow during the occlusion and reperfusion after removal of the 
clips was visually confirmed and the incision was closed with 4-0 silk sutures. The onset of cerebral 
ischemia was associated with a brief period of panting breathing and body movements followed by 
quiescence. Successful occlusion of both carotid arteries was evident with the rapid onset of complete 
bilateral ptosis and the adoption of a ‘hunched’ posture. In sham-operated animals, the arteries were freed 
from connective tissue but were not occluded. The rectal temperature was carefully monitored and 
maintained at 37 ± 0.5°C using an incandescent lamp and the animals were allowed to recover on an 
electrical heated blanket. In addition, rectal temperature was monitored at 6-h intervals until sacrificing the 
animals in all experimental groups.  
 
2.2. Drug treatments 
The following experimental groups were prepared: a sham-operated group (n=7), an ischemic group treated with 
the vehicle of nimesulide (polyvinylpyrrolidone, n=9) and three groups of ischemic gerbils treated with nimesulide 
at doses of 3 mg/kg (n=7), 6 mg/kg (n=9) and 12 mg/kg (n=9) given intraperitoneally starting after 6 h of 
reperfusion (delayed treatment schedule). Additional doses of nimesulide or vehicle were administered at 12, 24 
and 36 h of reperfusion. These doses and treatment paradigm were based on our previous results showing 
marked neuroprotective efficacy of nimesulide in this gerbil model of cerebral ischemia (Candelario-Jalil et al., 
2002b). Three different groups of sham-operated animals (n=7 each) treated with nimesulide using the same 
doses (3, 6 and 12 mg/kg) and treatment schedule of those ischemic animals treated with the inhibitor were also 
included. We also performed an experiment in which nimesulide (6 mg/kg) was administered 30 minutes before 
ischemia and again at 6, 12, 24 and 36 h of reperfusion (pre-treatment schedule, n=9). A vehicle pre-treated 
group was also included (n=7).  
 
2.3. Brain sampling 
Animals were sacrificed after 48 h of reperfusion, because according to our previous results, hippocampal 
oxidative damage (significant depletion in reduced glutathione and a marked increase in oxidized 
glutathione, malondialdehyde and 4-hydroxy-alkenals levels) is maximal at this time point in gerbil global 
cerebral ischemia (Candelario-Jalil et al., 2001). Gerbils were deeply anesthetized with diethyl ether and 
perfused transcardially with ice-cold saline to flush all blood components from the vasculature. Brains were 
quickly removed, kept in ice-cold saline and hippocampi were immediately dissected out on a chilled plate, 
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exactly as in our previous reports (Candelario-Jalil et al., 2000, 2001; Martínez et al., 2001). Hippocampi 
were weighed and homogenized in ice-cold 20 mM Tris-HCl buffer (pH 7.4) and centrifuged for 10 min at 
12 000 g. The supernatant was collected, frozen at -70°C and employed for biochemical analyses.  
 
2.4. Glutathione determination 
Reduced and oxidized glutathione (GSH and GSSG, respectively) were measured enzymatically in 5-
sulphosalycilic acid-deproteinized samples by using a modification (Anderson, 1985) of the procedure of 
Tietze (1969) as described for brain samples (Floreani et al., 1997). The method is based on the 
determination of a chromophoric product, 2-nitro-5-thiobenzoic acid, resulting from the reaction of 5,5’-
dithiobis(2-nitrobenzoic acid) with GSH. In this reaction, GSH is oxidized to GSSG, which is then 
reconverted to GSH in the presence of glutathione reductase (type III, from Saccharomyces cerevisiae, 
Randox Laboratories, Antrim, UK) and NADPH. The rate of 2-nitro-5-thiobenzoic acid formation, which is 
proportional to the sum of GSH and GSSG present, is followed at 412 nm. Samples were assayed rapidly 
to minimize GSH oxidation. Specificity of this method for glutathione quantification is ensured by highly 
specific glutathione reductase. GSH present in the samples was calculated as the difference between total 
glutathione and GSSG levels, taking into account the fact that one molecule of GSSG gives rise to two 
molecules of GSH upon reaction with glutathione reductase. A standard curve with known amounts of GSH 
was established and employed for estimating glutathione content. 
 
2.5. Lipid peroxidation assays 
Lipid peroxidation was assessed by measuring the concentration of malondialdehyde (MDA) and 4-
hydroxy-alkenals (4-HDA) and by determining the levels of lipid hydroperoxides in brain samples. 
Concentrations of MDA and 4-HDA were analyzed using the LPO-586 kit obtained from Calbiochem (La 
Jolla, CA, USA). In the assay, the production of a stable chromophore after 40 min of incubation at 45°C 
was measured at a wavelength of 586 nm. For standards, freshly prepared solutions of malondialdehyde 
bis [dimethyl acetal] (Sigma) and 4-hydroxy-nonenal diethylacetal (Cayman Chemical, Ann Arbor, MI, USA) 
were employed and assayed under identical conditions. Concentrations of MDA and 4-HDA in brain 
samples were calculated using the corresponding standard curve and values were expressed as nmol 
MDA+4-HDA per mg protein. This procedure has been used widely for the measurement of products of 
lipid peroxidation in brain homogenates (Chabrier et al., 1999; Candelario-Jalil et al., 2000, 2001). Lipid 
hydroperoxides were measured with ferrous oxidation-xylenol orange assay (Gay et al., 1999) as reported 
for brain homogenates (Song et al., 1999; Candelario-Jalil et al., 2001). Hydrogen peroxide was used as 
reference standard (R=0.997). Lipid hydroperoxides levels were expressed as nmol hydroperoxides per mg 
protein. 
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2.6. Fluoro-Jade B staining 
We also performed histochemical analyses of brain samples obtained from ischemic animals treated with 
nimesulide in order to confirm the neuroprotective effect of this compound against hippocampal CA1 
neuronal loss following transient global ischemia (Candelario-Jalil et al., 2002b). We employed the novel 
high affinity fluorescent marker Fluoro-Jade B for the localization of neuronal degeneration following 
ischemia (Schmued and Hopkins, 2000). Three different groups of gerbils were prepared: a sham-operated 
group (n=5), a vehicle-treated ischemic group (n=7) and a nimesulide-treated group (6 mg/kg; i.p., starting 
after 6 h of reperfusion, n=7). Taking into account that previous studies have found marked neuroprotective 
effects with nimesulide at the dose of 6 mg/kg in different models of brain injury (Candelario-Jalil et al., 
2000, 2002b; Cernak et al., 2001, 2002), we decided to select this dose for this experiment. At 7 days after 
ischemia, animals were anesthetized with diethyl ether and then perfused transcardially with 0.1 M neutral 
phosphate buffered 10 % formalin (4 % formaldehyde). The brains were post-fixed overnight in the same 
fixative solution plus 20% sucrose. Brain tissue was cut on a freezing sliding microtome at a thickness of 
25 μm. Three sections per animal containing the dorsal hippocampus were obtained at three levels (-1.0, -
1.5 and -2.2 mm relative to bregma) and stained with Fluoro-Jade B for detection of degenerating neurons. 
Sections were mounted on 2% gelatin-coated slides and then air dried on a slide warmer at 50ºC for half 
an hour. The slides were first immersed in a solution containing 1% sodium hydroxide in 80% alcohol for 5 
min. This was followed by 2 min in 70% alcohol and 2 min in distilled water. The slides were then 
transferred to a solution of 0.06% potassium permanganate for 10 min on a shaker table. The slides were 
then rinsed in distilled water for 2 min and transferred to a 0.0004% Fluoro-Jade B (Histochem, Jefferson, 
AR, USA) staining solution prepared in 0.1% acetic acid. After 20 min in the staining solution, the slides 
were rinsed for 1 min in each of three distilled water washes. Excess water was removed by briefly draining 
the slides vertically on a paper towel. The slides were then placed on a slide warmer, set at approximately 
50ºC, until they were fully dry (aprox. 8 min). The dry slides were cleared by immersion in xylene for at 
least a min before coverslipping with DPX (Fluka, Milwaukee, WI, USA), a non-aqueous, non-fluorescent 
plastic mounting media. The slides were then examined using an epifluorescent microscope (Olympus, 
Tokyo, Japan) with blue (450-490 nm) excitation light and a barrier filter that allows passage of all 
wavelengths longer than 515 nm, resulting in a yellow emission color. With this method neurons that 
undergo degeneration brightly fluoresce in comparison to the background (Fig. 2) (Schmued and Hopkins, 
2000). Images of the hippocampal CA1 stratum pyramidale area for both hemispheres were digitized using 
a CCD camera (Mavica, Sony, Japan). In each image, a rectangular box (0.25 x 1 mm) was centered over 
the CA1 cell layer beginning 1.0 mm lateral to the midline to maintain consistency across animals. An 
investigator who was uninformed of animal group identity, independently counted the number of fluorescing 
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(positive) neurons in each brain image. The mean number of Fluoro-Jade B-positive neurons was 
calculated for each treatment group (Lyeth et al., 2001).  
 
2.7. Protein assay 
Total protein concentrations were analyzed using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA, 
USA). Analytical grade bovine serum albumin was used to establish a standard curve.  
 
2.8. Statistical analysis 
Data are expressed as mean ± standard deviation (S.D.). Statistical analysis was performed with one-way 
ANOVA followed by a Student-Newman-Keuls post-hoc test. The value of P less than 0.05 was considered 
to be statistically significant. 
 
3. Results 
3.1. Effects of nimesulide on ischemia-induced hippocampal glutathione depletion 
We have previously reported a significant late-onset (48-72 h) persistent glutathione depletion in 
hippocampus after global cerebral ischemia in gerbils (Candelario-Jalil et al., 2001). In the present study, 
the ANOVA revealed a significant effect of post-ischemic nimesulide treatment on glutathione homeostasis 
(P<0.05) compared to vehicle control (Table 1). Post-hoc analysis using the Student-Newman-Keuls test 
demonstrated that the three doses of nimesulide conferred a similar protection against the significant 
reduction in levels of GSH and increase in GSSG as shown in Table 1. Although there were no statistically 
significant differences among the nimesulide doses, in general, there was a trend toward a better 
neuroprotection with the highest doses (6 and 12 mg/kg). When nimesulide was administered before 
ischemia, no additional positive effects were noticed, as presented in Table 1. Administration of nimesulide 
to sham-operated animals failed to significantly modify hippocampal glutathione levels (Table 2).   
 
3.2. Effects of clinically relevant doses of nimesulide on measures of lipid peroxidation in ischemic 
hippocampus 
Malondialdehyde (MDA), 4-hydroxy-alkenals (4-HDA) and lipid hydroperoxides were used as indicators of 
lipid peroxidation in homogenates of hippocampus. In these studies, the ANOVA test resulted in a 
significant effect (P<0.05) of drug treatment on lipid peroxidation at 48 h following transient global cerebral 
ischemia. The Student-Newman-Keuls post-hoc analysis revealed that lipid peroxidation was significantly 
reduced by the delayed treatment with nimesulide compared to vehicle-treated ischemic animals (Fig. 1A 
and 1B). Similarly, no further protection was afforded by an additional drug treatment 30 min prior to 
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ischemia (Fig. 1). On the other hand, administration of nimesulide (3, 6 or 12 mg/kg) to sham-operated 
animals failed to significantly modify lipid peroxidation markers (Table 2). 
 
3.3. Histofluorescence evidence of nimesulide neuroprotection against ischemia-induced hippocampal CA1 
neuronal loss: Fluoro-Jade B staining 
The Fluoro-Jade B histofluorescence technique stained only degenerating neurons indicated by a bright 
fluorescence and was remarkably helpful in identifying neurodegeneration (Schmued and Hopkins, 2000). 
A representative Fluoro-Jade B labeling in the hippocampus is presented in Fig. 2. No Fluoro-Jade B 
positive fluorescence staining was noted in the hippocampal region of control animals (sham-operated 
control group) as shown in Fig. 2A. On the contrary, hippocampal sections from vehicle-treated ischemic 
gerbils showed a dramatic increase in Fluoro-Jade B positive cells in the CA1 pyramidal cell layer (Fig. 2B), 
whereas very few positive cells were seen in similar sections of the nimesulide-treated animals (Fig. 2C). 
Fig. 2D shows the quantitative analysis of Fluoro-Jade B-labeled neurons in the CA1 region of 
hippocampus in each treatment group. The neuroprotective effect of nimesulide as seen by Fluoro-Jade B 
(a specific marker of neuronal degeneration) supports our previous findings using a standard hematoxylin-
eosin staining technique (Candelario-Jalil et al., 2002b).  
 
The protection conferred by nimesulide in the present study is not attributable to effects on body 
temperature because this variable was carefully monitored and did not differ between treated and non-
treated groups (data not shown). 
 
4. Discussion 
The results of the present study provide evidence that the neuroprotective effects of nimesulide are 
mediated, at least in part, through reduction of oxidative stress following transient global cerebral ischemia. 
In addition, these findings demonstrate that cyclooxygenase-2 selective inhibitors can reduce these 
oxidative events in the ischemic hippocampus, suggesting that cyclooxygenase-2 is involved in the late 
increase in measures of oxidative injury in the damaged brain.   
 
Glutamate-induced excitotoxic damage, reactive oxygen species formation, and the generation of lipid 
peroxidation products (MDA, 4-HDA, lipid hydroperoxides) are prominent events thought to contribute to 
neuronal dysfunction and cell loss following traumatic damage and ischemic injury to the CNS (Facchinetti 
et al., 1998; Urabe et al., 2000; Chan, 2001). Sustained activation of glutamate receptors and the influx of 
Ca2+ have been shown in many different models to result in the generation of highly reactive oxygen 
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species (Coyle and Puttfarcken, 1993; Dugan et al., 1995), which are able to attack critical cellular 
components, including DNA, proteins and phospholipids (Halliwell and Gutteridge, 1985; Chan, 2001).  
 
Several experimental evidences indicate that lipid peroxidation results in loss of membrane integrity, 
impairment of the function of membrane-transport proteins and ion channels, disruption of cellular ion 
homeostasis and concomitantly increases neuronal vulnerability to excitotoxicity (Mattson, 1998; Springer 
et al., 1997). In addition, several studies have demonstrated that glutamate uptake is compromised by 
pathophysiological events associated with the generation of free radical species (Volterra et al., 1994; 
Keller et al., 1997; Springer et al., 1997). Dysfunction of the glutamate transporters can lead to neuronal 
damage by allowing glutamate to remain in the synaptic cleft for a longer duration, contributing to 
excitotoxicity-induced oxidative injury in the ischemic brain.  
 
Results from different studies indicate that oxidative damage in the gerbil hippocampus is maximal at late 
stages after ischemia (Hall et al., 1997; Oostveen et al., 1998; Yamaguchi et al., 1998; Urabe et al., 2000; 
Candelario-Jalil et al., 2001). The delayed occurrence of oxidative stress correlates well with delayed 
neuronal loss of hippocampal CA1 pyramidal neurons (Hall et al., 1993, 1997; Oostveen et al., 1998), 
suggesting that reactive oxygen species formation may cooperate in a series of molecular events that link 
ischemic injury to neuronal cell death. 
 
It is noteworthy that a delayed treatment with the cyclooxygenase-2 inhibitor nimesulide is able to reduce 
the late-onset oxidative injury in the ischemic hippocampus (Table 1 and Fig. 1). This might suggests that 
cyclooxygenase-2 is a critical source of free radicals at later times following global cerebral ischemia, since 
no further protection was observed when this cyclooxygenase-2 inhibitor was administered 30 min before 
ischemia. Cyclooxygenase-2 is one of a select few proteins that still remains upregulated in CA1 
hippocampal cells even at 3 days after ischemia (Nakayama et al., 1998; Koistinaho et al., 1999), thus 
preceding the death of these neurons.  
 
The production of pro-inflammatory prostanoids is another injurious mechanism associated to the 
cyclooxygenase-2 enzymatic activity (Marnett et al., 1999). Interestingly, prostaglandins have been shown 
to stimulate calcium-dependent glutamate release in astrocytes (Bezzi et al., 1998), thus contributing to 
excitotoxicity. Pharmacological inhibition of COX-2 has been shown to reduce N-methyl-D-aspartate-
mediated neuronal cell death both in vitro (Hewett et al., 2000) and in vivo (Iadecola et al., 2001). In 
addition, recent investigations have found a potentiation of excitotoxicity in transgenic mice overexpressing 
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neuronal COX-2 (Kelley et al., 1999) and a significant reduction in ischemic brain injury in COX-2-deficient 
mice (Iadecola et al., 2001). 
 
Probably the most important and significant alteration in the antioxidant system is a decrease in reduced 
glutathione content (Schulz, 2000). Nimesulide treatment was able to confer protection against 
hippocampal glutathione depletion (Table 1) and the ensuing lipid peroxidation as assessed by the 
increases in MDA, 4-HDA and lipid hydroperoxides levels. No significant modification in lipid peroxidation 
was observed in animals treated with nimesulide without ischemia (sham-operated animals; Table 2). This 
result suggests that administration of cyclooxygenase-2 inhibitors does not modify basal lipid peroxidation 
in brain possibly due to the low expression of this enzyme under physiological conditions (Seibert et al., 
1997). On the contrary, inhibition of cyclooxygenase-2 with nimesulide at 48 h after the ischemic episode, 
significantly reduced lipid peroxidation and glutathione depletion, indicating that under damaging conditions 
to the brain, cyclooxygenase-2 contributes to damage through a mechanism involving production of highly 
reactive free radicals.  
 
The biochemical evidence of reduction of oxidative stress by nimesulide in hippocampus and its 
neuroprotective efficacy is supported by the histofluorescence findings using the specific fluorescent 
marker Fluoro-Jade B (Fig. 2). It is important to emphasize that these beneficial effects were seen at doses 
that are well tolerated in patients with minimal side effects. These findings are in line with other studies, 
which have shown that cyclooxygenase inhibitors are able to reduce free radical production in cerebral 
ischemia (Hall et al., 1993; Domoki et al., 2001; Miyamoto et al., 2003) and in traumatic brain injury (Tyurin 
et al., 2000). 
 
In summary, the results of the present study indicate that nimesulide confers protection against ischemic 
global brain injury through a mechanism that involves reduction of oxidative damage. Although other 
mechanisms might also be involved, we believe that inhibition of cyclooxygenase-2 with the concomitant 
attenuation of oxidative stress and prostaglandin accumulation is the main event accounting for the 
neuroprotective properties of nimesulide. Our findings are consistent with the hypothesis that reducing 
oxidative events should prove beneficial in promoting cell function and survival following ischemic brain 
injury and likely hold a therapeutic promise to intervene neuronal injury evolving after global cerebral 
ischemia with the cyclooxygenase-2 inhibitor nimesulide.  
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Table 1. Effect of the selective COX-2 inhibitor nimesulide on ischemia-induced glutathione depletion in the 
hippocampus after 48 h of reperfusion following 5 min global cerebral ischemia. 
 
Groups GSH (μg/g tissue) GSSG (ng/g tissue) 
Delayed treatment schedule   
Sham  1.53 ± 0.19 1.52 ± 1.28 
Ischemia + Vehicle 0.99 ± 0.21 ** 10.24 ± 3.16 ** 
Ischemia + Nimesulide (3 mg/kg) 1.21 ± 0.14 ‡ *  6.82 ± 1.94 ‡ * 
Ischemia + Nimesulide (6 mg/kg) 1.35 ± 0.24 ‡ * 5.33 ± 2.08 ‡ * 
Ischemia + Nimesulide (12 mg/kg) 1.32 ± 0.18 ‡ * 5.71 ± 3.16 ‡ * 
Pretreatment   
Ischemia + Vehicle 1.02 ± 0.18 ** 9.84 ± 3.55 **  
Ischemia + Nimesulide (6 mg/kg) 1.29 ± 0.26 † *  5.11 ± 2.17 † * 
Data are mean ± S.D. ** P<0.01 compared to sham. ‡ P<0.05 compared to vehicle (delayed treatment).  
*P<0.05 compared to sham. †p<0.05 compared to vehicle (pretreatment). ANOVA followed by Student-
Newman-Keuls post-hoc test.  
 
 
Table 2. Lack of effect of the selective COX-2 inhibitor nimesulide on oxidative stress parameters in sham-
operated animals. 
Groups 
GSH 
(μg/g tissue)
GSSG 
(ng/g tissue) 
MDA + 4-HDA 
(nmol/mg protein) 
Hydroperoxides 
(nmol/mg protein) 
Sham + Vehicle  1.53 ± 0.19 1.52 ± 1.28 3.1 ± 2.1 22.4 ± 2.4 
Sham +  
Nimesulide (3 mg/kg) 
 1.48 ± 0.20 1.55 ± 0.98 2.9 ± 1.9 23.3 ± 1.7 
Sham +  
Nimesulide (6 mg/kg) 
 1.51 ± 0.17 1.49 ± 1.02 2.8 ± 1.3 22.6 ± 2.1 
Sham +  
Nimesulide (12 
mg/kg) 
 1.56 ± 0.21 1.53 ± 0.97 3.0 ± 0.9 20.8 ± 1.8 
Data are mean ± S.D.  
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Fig. 1. Effect of delayed treatment with different doses of nimesulide on 
markers of lipid peroxidation in hippocampus at 48 h after 5 min of transient 
forebrain ischemia in gerbils. Malondialdehyde (MDA) and 4-hydroxy-
alkenals (4-HDA) (A) and lipid hydroperoxides levels (B) were determined 
as measures of lipid peroxidation. Data are mean ± S.D. **P<0.01 
compared to sham. ‡P<0.05 with respect to vehicle-treated animals. 
&P<0.05 with respect to vehicle (pretreatment). ANOVA followed by 
Student-Newman-Keuls post-hoc test. 
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 Fig. 2. Neuroprotective effect of nimesulide on hippocampal sections as stained with Fluoro-Jade B. 
This novel reagent labels degenerating cells in yellow, whereas normal cells appear unstained. A, 
CA1 region of hippocampus in the control (sham-operated) animals show no Fluoro-Jade B positive 
cells. B, CA1 region of hippocampus in vehicle-treated ischemic gerbils shows extensive labeling in 
nearly all pyramidal neurons. C, CA1 region of hippocampus in ischemic animals treated with 
nimesulide (6 mg/kg) shows few Fluoro-Jade B positive cells. D, Cell counts of degenerating 
neurons in the CA1 sector of dorsal hippocampus and neuroprotective effect of the COX-2 inhibitor 
nimesulide (6 mg/kg; starting after 6 h of reperfusion). Bars represent the group means (+S.D.). 
**P<0.01 compared with vehicle. Bar =200 μm in panels A, B and C. 
